Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
Exopolysaccharide Produced by <i>Lactiplantibacillus plantarum</i>-12 Alleviates Intestinal Inflammation and Colon Cancer Symptoms by Modulating the Gut Microbiome and Metabolites of C57BL/6 Mice Treated by Azoxymethane/Dextran Sulfate Sodium Salt
oleh: Fenglian Ma, Yinglong Song, Mengying Sun, Arong Wang, Shujuan Jiang, Guangqing Mu, Yanfeng Tuo
| Format: | Article |
|---|---|
| Diterbitkan: | MDPI AG 2021-12-01 |
Deskripsi
Exopolysaccharide produced by <i>Lactiplantibacillus plantarum</i>-12 (LPEPS) exhibited the anti-proliferating effect on human colon cancer cell line HT-29 in vitro. The purpose of the study was to determine the alleviating effects of LPEPS on colon cancer development of the C57BL/6 mice treated by azoxymethane/dextran sulfate sodium salt (AOM/DSS). The C57BL/6 mice treated by AOM/DSS were orally administered LPEPS daily for 85 days. The results showed that LPEPS oral administration enhanced colon tight-junction protein expression and ameliorated colon shortening and tumor burden of the AOM/DSS treated mice. Furthermore, LPEPS oral administration significantly reduced pro-inflammatory factors TNF-α, IL-8, and IL-1β levels and increased anti-inflammatory factor IL-10 level in the serum of the AOM/DSS-treated mice. LPEPS oral administration reversed the alterations of gut flora in AOM/DSS-treated mice, as evidenced by the increasing of the abundance of <i>Bacteroidetes</i>, <i>Bacteroidetes</i>/<i>Firmicutes</i> ratio, <i>Muribaculaceae</i>, <i>Burkholderiaceae</i>, and <i>norank_o__Rhodospirillales</i> and the decreasing of the abundance of <i>Firmicutes</i>, <i>Desulfovibrionaceae</i>, <i>Erysipelotrichaceae</i>, and <i>Helicobacteraceae</i>. The fecal metabolites of the AOM/DSS-treated mice were altered by LPEPS oral administration, involving lipid metabolism and amino acid metabolism. Together, these results suggested that LPEPS oral administration alleviated AOM/DSS-induced colon cancer symptoms of the C57BL/6 mice by modulating gut microbiota and metabolites, enhancing intestine barrier, inhibiting NF-κB pathway, and activating caspase cascade.